Article Text

Download PDFPDF
Comparison of biometric and refractive changes in intermittent exotropia with and without overminus lens therapy
  1. Jit B Ale Magar1,
  2. Shaheen P Shah1,2,
  3. Shuan Dai2,3
  1. 1 Ophthalmology, Queensland Children's Hospital, South Brisbane, Queensland, Australia
  2. 2 School of Clinical Medicine, The University of Queensland, Saint Lucia, Queensland, Australia
  3. 3 Department of Ophthalmology, Queensland Children's Hospital, South Brisbane, Queensland, Australia
  1. Correspondence to Dr Jit B Ale Magar, Queensland Health, Brisbane, QLD 4101, Australia; jeetopt{at}yahoo.com

Abstract

Background Overminus lens is an effective non-surgical treatment of intermittent exotropia (IXT). Whether this treatment causes development of myopia is recently debated. This study evaluated ocular biometric changes in IXT children treated with and without overminus lens.

Methods Children with IXT were randomly assigned to control and overminus groups. Cycloplegic refraction, axial length and other parameters (keratometry, anterior chamber depth and lens thickness) were evaluated for up to 30 months and compared between the groups. Axial length to corneal curvature (AL/CR) ratio was examined as an indicator of myopia progression. Changes prior to and after overminus were also assessed in a subgroup.

Results Mean age of the total 84 subjects (58% women) was 7.2 years (range 4–15 years). Baseline refractive and biometric parameters of 39 control and 45 overminus subjects were not significantly different. Mean±SD change in refraction was −0.34±0.45D in controls and −0.41±0.66D in overminus group (p=0.527). AL increased by 0.29±0.20 millimetre (mm) in controls and 0.28±0.23 mm in overminus group (p=0.766). In the subgroup, the changes before and after overminus therapy was not significantly different (p>0.05). AL/CR ratio was maintained from baseline to follow-up visit (p=0.298) in both groups.

Conclusion No significant differences in biometry or refraction were found between the two groups and before and after the therapy. We conclude that the overminus therapy in children, not accounting for other myopia risk factors, does not affect normal refractive growths.

  • Clinical Trial
  • Optics and Refraction

Data availability statement

Data are available upon reasonable request. Data may be obtained from a third party and are not publicly available. Data available on request.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request. Data may be obtained from a third party and are not publicly available. Data available on request.

View Full Text

Footnotes

  • Contributors JBAM: Planned study design, prepared protocol, collected data, analysed and drafted manuscript. SPS: Designed the study, collected data, analysed, critically reviewed manuscript and approved. SD: Planned, analysed data, prepared manuscript, reviewed and approved and is responsible for the overall content as guarantor.

  • Funding Supported by ‘Study, Education and Research Trust Account (SERTA)’ Grant, Queensland Children’s Hospital.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles

  • Highlights from this issue
    Frank Larkin